138 related articles for article (PubMed ID: 22762724)
21. The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus.
Chen J; Wang Q; Li R; Li Z; Jiang Q; Yan F; Ye J
Life Sci; 2023 Nov; 333():122187. PubMed ID: 37858715
[TBL] [Abstract][Full Text] [Related]
22. Sirtuin modulators: an updated patent review (2012 - 2014).
Mellini P; Valente S; Mai A
Expert Opin Ther Pat; 2015 Jan; 25(1):5-15. PubMed ID: 25435179
[TBL] [Abstract][Full Text] [Related]
23. Sirtuins: novel targets for metabolic disease in drug development.
Jiang WJ
Biochem Biophys Res Commun; 2008 Aug; 373(3):341-4. PubMed ID: 18577374
[TBL] [Abstract][Full Text] [Related]
24. The role of sirtuins in the regulation of metabolic homeostasis in skeletal muscle.
Ryall JG
Curr Opin Clin Nutr Metab Care; 2012 Nov; 15(6):561-6. PubMed ID: 23075935
[TBL] [Abstract][Full Text] [Related]
25. SIRT1 in metabolic syndrome: where to target matters.
Wang Y; Xu C; Liang Y; Vanhoutte PM
Pharmacol Ther; 2012 Dec; 136(3):305-18. PubMed ID: 22939883
[TBL] [Abstract][Full Text] [Related]
26. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.
Björnholm M; Zierath JR
Biochem Soc Trans; 2005 Apr; 33(Pt 2):354-7. PubMed ID: 15787605
[TBL] [Abstract][Full Text] [Related]
27. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
28. Novel Polysaccharide H-1-2 from Pseudostellaria Heterophylla Alleviates Type 2 Diabetes Mellitus.
Fang ZH; Duan XC; Zhao JD; Wu YJ; Liu MM
Cell Physiol Biochem; 2018; 49(3):996-1006. PubMed ID: 30196291
[TBL] [Abstract][Full Text] [Related]
29. Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?
Song J; Yang B; Jia X; Li M; Tan W; Ma S; Shi X; Feng L
Front Endocrinol (Lausanne); 2018; 9():724. PubMed ID: 30559718
[TBL] [Abstract][Full Text] [Related]
30. Sirtuin function and metabolism: Role in pancreas, liver, and adipose tissue and their crosstalk impacting bone homeostasis.
Avilkina V; Chauveau C; Ghali Mhenni O
Bone; 2022 Jan; 154():116232. PubMed ID: 34678494
[TBL] [Abstract][Full Text] [Related]
31. [Research advances in Sirt1 gene].
Qiao AJ; Zhiao J; Liu XJ; Shao D; Zhu LL; Cui AF; Kong XX; Fang FD; Chang YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Dec; 31(6):782-5. PubMed ID: 20078953
[TBL] [Abstract][Full Text] [Related]
32. Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes.
Pfefferkorn JA
Expert Opin Drug Discov; 2013 Mar; 8(3):319-30. PubMed ID: 23289965
[TBL] [Abstract][Full Text] [Related]
33. Metabolic actions of hypothalamic SIRT1.
Coppari R
Trends Endocrinol Metab; 2012 Apr; 23(4):179-85. PubMed ID: 22382036
[TBL] [Abstract][Full Text] [Related]
34. A patent review of sirtuin activators: an update.
Villalba JM; de Cabo R; Alcain FJ
Expert Opin Ther Pat; 2012 Apr; 22(4):355-67. PubMed ID: 22475539
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome?
Beaudeux JL; Nivet-Antoine V; Giral P
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):729-36. PubMed ID: 20823772
[TBL] [Abstract][Full Text] [Related]
36. Thoughts on the progression of type 2 diabetes drug discovery.
Bhatt HB
Expert Opin Drug Discov; 2015 Feb; 10(2):107-10. PubMed ID: 25534140
[TBL] [Abstract][Full Text] [Related]
37. The metabolic sensor Sirt1 and the hypothalamus: Interplay between peptide hormones and pro-hormone convertases.
Nillni EA
Mol Cell Endocrinol; 2016 Dec; 438():77-88. PubMed ID: 27614022
[TBL] [Abstract][Full Text] [Related]
38. Effects of caloric restriction on SIRT1 expression and apoptosis of islet beta cells in type 2 diabetic rats.
Deng X; Cheng J; Zhang Y; Li N; Chen L
Acta Diabetol; 2010 Dec; 47 Suppl 1():177-85. PubMed ID: 19876588
[TBL] [Abstract][Full Text] [Related]
39. SIRT1, metabolism and cancer.
Knight JR; Milner J
Curr Opin Oncol; 2012 Jan; 24(1):68-75. PubMed ID: 22080944
[TBL] [Abstract][Full Text] [Related]
40. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38.
Aksoy P; Escande C; White TA; Thompson M; Soares S; Benech JC; Chini EN
Biochem Biophys Res Commun; 2006 Oct; 349(1):353-9. PubMed ID: 16935261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
